title: Rituximab in the treatment of acquired factor VIII inhibitors.
authors.affiliation: Department of Hematology/Oncology, Marshfield Clinic-Weston Center, 3501 Cranberry Boulevard, Weston, WI 54476, USA. onitilo.adedayo@marshfieldclinic.org
authors.forename: Adedayo A
authors.initials: AA
authors.lastname: Onitilo
authors.forename: Amy
authors.initials: A
authors.lastname: Skorupa
authors.forename: Asheesh
authors.initials: A
authors.lastname: Lal
authors.forename: Elizabeth
authors.initials: E
authors.lastname: Ronish
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Mercier
authors.forename: Rezwan
authors.initials: R
authors.lastname: Islam
authors.forename: John
authors.initials: J
authors.lastname: Lazarchick
mesh_terms: D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D058846:Antibodies, Monoclonal, Murine-Derived; D000917:Antibody Formation; D001323:Autoantibodies / Q000097:blood*; D005169:Factor VIII / Q000276:immunology*; D005260:Female; D006467:Hemophilia A / Q000188:drug therapy* / Q000209:etiology; D006470:Hemorrhage / Q000209:etiology; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D000069283:Rituximab; D013927:Thrombosis / Q000209:etiology
chemical_list: D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D001323:Autoantibodies; D007166:Immunosuppressive Agents; D000069283:Rituximab; D005169:Factor VIII